nodes	percent_of_prediction	percent_of_DWPC	metapath
Roflumilast—PDE4C—DARPP-32 events—CALM3—ulcerative colitis	0.00921	0.0489	CbGpPWpGaD
Roflumilast—PDE4D—DARPP-32 events—CALM3—ulcerative colitis	0.00802	0.0425	CbGpPWpGaD
Roflumilast—PDE4A—DARPP-32 events—CALM3—ulcerative colitis	0.00763	0.0405	CbGpPWpGaD
Roflumilast—PDE4B—DARPP-32 events—CALM3—ulcerative colitis	0.00706	0.0375	CbGpPWpGaD
Roflumilast—PDE4D—TSH signaling pathway—GNA12—ulcerative colitis	0.00547	0.029	CbGpPWpGaD
Roflumilast—PDE4C—G Protein Signaling Pathways—GNA12—ulcerative colitis	0.00477	0.0253	CbGpPWpGaD
Roflumilast—PDE4D—G Protein Signaling Pathways—GNA12—ulcerative colitis	0.00416	0.0221	CbGpPWpGaD
Roflumilast—PDE4A—G Protein Signaling Pathways—GNA12—ulcerative colitis	0.00396	0.021	CbGpPWpGaD
Roflumilast—PDE4C—Opioid Signalling—CALM3—ulcerative colitis	0.00371	0.0197	CbGpPWpGaD
Roflumilast—PDE4B—G Protein Signaling Pathways—GNA12—ulcerative colitis	0.00366	0.0194	CbGpPWpGaD
Roflumilast—PDE4D—Opioid Signalling—CALM3—ulcerative colitis	0.00323	0.0171	CbGpPWpGaD
Roflumilast—PDE4A—Opioid Signalling—CALM3—ulcerative colitis	0.00307	0.0163	CbGpPWpGaD
Roflumilast—PDE4C—G alpha (s) signalling events—PTGER4—ulcerative colitis	0.00298	0.0158	CbGpPWpGaD
Roflumilast—PDE4B—Opioid Signalling—CALM3—ulcerative colitis	0.00284	0.0151	CbGpPWpGaD
Roflumilast—PDE4C—Opioid Signalling—ADCY5—ulcerative colitis	0.00269	0.0143	CbGpPWpGaD
Roflumilast—PDE4D—G alpha (s) signalling events—PTGER4—ulcerative colitis	0.00259	0.0137	CbGpPWpGaD
Roflumilast—PDE4A—G alpha (s) signalling events—PTGER4—ulcerative colitis	0.00247	0.0131	CbGpPWpGaD
Roflumilast—PDE4C—G Protein Signaling Pathways—ADCY5—ulcerative colitis	0.00241	0.0128	CbGpPWpGaD
Roflumilast—PDE4D—Opioid Signalling—ADCY5—ulcerative colitis	0.00234	0.0124	CbGpPWpGaD
Roflumilast—PDE4B—G alpha (s) signalling events—PTGER4—ulcerative colitis	0.00228	0.0121	CbGpPWpGaD
Roflumilast—PDE4C—G alpha (s) signalling events—ADRB2—ulcerative colitis	0.00226	0.012	CbGpPWpGaD
Roflumilast—PDE4A—Opioid Signalling—ADCY5—ulcerative colitis	0.00223	0.0118	CbGpPWpGaD
Roflumilast—PDE4D—G Protein Signaling Pathways—ADCY5—ulcerative colitis	0.0021	0.0111	CbGpPWpGaD
Roflumilast—PDE4B—Opioid Signalling—ADCY5—ulcerative colitis	0.00206	0.0109	CbGpPWpGaD
Roflumilast—PDE4A—G Protein Signaling Pathways—ADCY5—ulcerative colitis	0.002	0.0106	CbGpPWpGaD
Roflumilast—PDE4D—G alpha (s) signalling events—ADRB2—ulcerative colitis	0.00196	0.0104	CbGpPWpGaD
Roflumilast—PDE4D—Myometrial Relaxation and Contraction Pathways—CALM3—ulcerative colitis	0.00192	0.0102	CbGpPWpGaD
Roflumilast—PDE4C—G alpha (s) signalling events—ADCY5—ulcerative colitis	0.00191	0.0102	CbGpPWpGaD
Roflumilast—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—ulcerative colitis	0.0019	0.00234	CcSEcCtD
Roflumilast—Discomfort—Mesalazine—ulcerative colitis	0.00189	0.00232	CcSEcCtD
Roflumilast—PDE4A—G alpha (s) signalling events—ADRB2—ulcerative colitis	0.00187	0.00992	CbGpPWpGaD
Roflumilast—Feeling abnormal—Budesonide—ulcerative colitis	0.00185	0.00228	CcSEcCtD
Roflumilast—PDE4B—G Protein Signaling Pathways—ADCY5—ulcerative colitis	0.00185	0.0098	CbGpPWpGaD
Roflumilast—Gastrointestinal pain—Budesonide—ulcerative colitis	0.00184	0.00227	CcSEcCtD
Roflumilast—Musculoskeletal discomfort—Azathioprine—ulcerative colitis	0.00183	0.00225	CcSEcCtD
Roflumilast—Infection—Mesalazine—ulcerative colitis	0.00182	0.00224	CcSEcCtD
Roflumilast—Connective tissue disorder—Hydrocortisone—ulcerative colitis	0.0018	0.00222	CcSEcCtD
Roflumilast—Nervous system disorder—Mesalazine—ulcerative colitis	0.00179	0.00221	CcSEcCtD
Roflumilast—Urticaria—Budesonide—ulcerative colitis	0.00179	0.0022	CcSEcCtD
Roflumilast—Abdominal pain—Budesonide—ulcerative colitis	0.00178	0.00219	CcSEcCtD
Roflumilast—Skin disorder—Mesalazine—ulcerative colitis	0.00178	0.00219	CcSEcCtD
Roflumilast—Weight decreased—Dexamethasone—ulcerative colitis	0.00177	0.00218	CcSEcCtD
Roflumilast—Weight decreased—Betamethasone—ulcerative colitis	0.00177	0.00218	CcSEcCtD
Roflumilast—Gastrointestinal disorder—Azathioprine—ulcerative colitis	0.00173	0.00214	CcSEcCtD
Roflumilast—PDE4B—G alpha (s) signalling events—ADRB2—ulcerative colitis	0.00173	0.00918	CbGpPWpGaD
Roflumilast—Rhinitis—Triamcinolone—ulcerative colitis	0.00173	0.00213	CcSEcCtD
Roflumilast—Rhinitis—Methylprednisolone—ulcerative colitis	0.00172	0.00213	CcSEcCtD
Roflumilast—PDE4D—TSH signaling pathway—JAK2—ulcerative colitis	0.00172	0.00913	CbGpPWpGaD
Roflumilast—PDE4B—Myometrial Relaxation and Contraction Pathways—CALM3—ulcerative colitis	0.00169	0.00898	CbGpPWpGaD
Roflumilast—Connective tissue disorder—Methylprednisolone—ulcerative colitis	0.00169	0.00208	CcSEcCtD
Roflumilast—Musculoskeletal discomfort—Mesalazine—ulcerative colitis	0.00167	0.00205	CcSEcCtD
Roflumilast—PDE4D—G alpha (s) signalling events—ADCY5—ulcerative colitis	0.00167	0.00884	CbGpPWpGaD
Roflumilast—Hypersensitivity—Budesonide—ulcerative colitis	0.00166	0.00204	CcSEcCtD
Roflumilast—Feeling abnormal—Azathioprine—ulcerative colitis	0.00166	0.00204	CcSEcCtD
Roflumilast—Insomnia—Mesalazine—ulcerative colitis	0.00165	0.00204	CcSEcCtD
Roflumilast—Immune system disorder—Hydrocortisone—ulcerative colitis	0.00165	0.00204	CcSEcCtD
Roflumilast—Gastrointestinal pain—Azathioprine—ulcerative colitis	0.00164	0.00202	CcSEcCtD
Roflumilast—Asthenia—Budesonide—ulcerative colitis	0.00161	0.00199	CcSEcCtD
Roflumilast—Dyspepsia—Mesalazine—ulcerative colitis	0.00161	0.00198	CcSEcCtD
Roflumilast—Mental disorder—Hydrocortisone—ulcerative colitis	0.0016	0.00198	CcSEcCtD
Roflumilast—Cardiac disorder—Methylprednisolone—ulcerative colitis	0.0016	0.00197	CcSEcCtD
Roflumilast—Malnutrition—Hydrocortisone—ulcerative colitis	0.00159	0.00196	CcSEcCtD
Roflumilast—Decreased appetite—Mesalazine—ulcerative colitis	0.00159	0.00196	CcSEcCtD
Roflumilast—Abdominal pain—Azathioprine—ulcerative colitis	0.00159	0.00196	CcSEcCtD
Roflumilast—PDE4A—G alpha (s) signalling events—ADCY5—ulcerative colitis	0.00159	0.00842	CbGpPWpGaD
Roflumilast—Gastrointestinal disorder—Mesalazine—ulcerative colitis	0.00158	0.00195	CcSEcCtD
Roflumilast—Fatigue—Mesalazine—ulcerative colitis	0.00158	0.00194	CcSEcCtD
Roflumilast—Constipation—Mesalazine—ulcerative colitis	0.00156	0.00193	CcSEcCtD
Roflumilast—Immune system disorder—Methylprednisolone—ulcerative colitis	0.00155	0.00191	CcSEcCtD
Roflumilast—Mediastinal disorder—Methylprednisolone—ulcerative colitis	0.00155	0.00191	CcSEcCtD
Roflumilast—Weight decreased—Prednisone—ulcerative colitis	0.00154	0.0019	CcSEcCtD
Roflumilast—Diarrhoea—Budesonide—ulcerative colitis	0.00154	0.0019	CcSEcCtD
Roflumilast—Ill-defined disorder—Prednisolone—ulcerative colitis	0.00151	0.00187	CcSEcCtD
Roflumilast—Depression—Prednisone—ulcerative colitis	0.00151	0.00186	CcSEcCtD
Roflumilast—Feeling abnormal—Mesalazine—ulcerative colitis	0.00151	0.00186	CcSEcCtD
Roflumilast—Mental disorder—Methylprednisolone—ulcerative colitis	0.00151	0.00186	CcSEcCtD
Roflumilast—Malnutrition—Methylprednisolone—ulcerative colitis	0.0015	0.00185	CcSEcCtD
Roflumilast—Gastrointestinal pain—Mesalazine—ulcerative colitis	0.0015	0.00184	CcSEcCtD
Roflumilast—Angioedema—Prednisolone—ulcerative colitis	0.00149	0.00184	CcSEcCtD
Roflumilast—Dizziness—Budesonide—ulcerative colitis	0.00149	0.00183	CcSEcCtD
Roflumilast—Hypersensitivity—Azathioprine—ulcerative colitis	0.00148	0.00182	CcSEcCtD
Roflumilast—Ill-defined disorder—Hydrocortisone—ulcerative colitis	0.00148	0.00182	CcSEcCtD
Roflumilast—Malaise—Prednisolone—ulcerative colitis	0.00147	0.00181	CcSEcCtD
Roflumilast—Dysgeusia—Triamcinolone—ulcerative colitis	0.00147	0.00181	CcSEcCtD
Roflumilast—PDE4B—G alpha (s) signalling events—ADCY5—ulcerative colitis	0.00147	0.00779	CbGpPWpGaD
Roflumilast—Vertigo—Prednisolone—ulcerative colitis	0.00147	0.00181	CcSEcCtD
Roflumilast—Angioedema—Hydrocortisone—ulcerative colitis	0.00146	0.00179	CcSEcCtD
Roflumilast—Urticaria—Mesalazine—ulcerative colitis	0.00145	0.00179	CcSEcCtD
Roflumilast—Back pain—Triamcinolone—ulcerative colitis	0.00145	0.00179	CcSEcCtD
Roflumilast—Abdominal pain—Mesalazine—ulcerative colitis	0.00145	0.00178	CcSEcCtD
Roflumilast—Malaise—Hydrocortisone—ulcerative colitis	0.00144	0.00177	CcSEcCtD
Roflumilast—Vertigo—Hydrocortisone—ulcerative colitis	0.00143	0.00176	CcSEcCtD
Roflumilast—Vomiting—Budesonide—ulcerative colitis	0.00143	0.00176	CcSEcCtD
Roflumilast—Rash—Budesonide—ulcerative colitis	0.00142	0.00175	CcSEcCtD
Roflumilast—Dermatitis—Budesonide—ulcerative colitis	0.00142	0.00175	CcSEcCtD
Roflumilast—Headache—Budesonide—ulcerative colitis	0.00141	0.00174	CcSEcCtD
Roflumilast—PDE4D—Myometrial Relaxation and Contraction Pathways—ADCY5—ulcerative colitis	0.00139	0.0074	CbGpPWpGaD
Roflumilast—Ill-defined disorder—Triamcinolone—ulcerative colitis	0.00139	0.00172	CcSEcCtD
Roflumilast—Ill-defined disorder—Methylprednisolone—ulcerative colitis	0.00139	0.00171	CcSEcCtD
Roflumilast—Diarrhoea—Azathioprine—ulcerative colitis	0.00137	0.00169	CcSEcCtD
Roflumilast—Discomfort—Prednisolone—ulcerative colitis	0.00137	0.00169	CcSEcCtD
Roflumilast—Angioedema—Triamcinolone—ulcerative colitis	0.00137	0.00169	CcSEcCtD
Roflumilast—Angioedema—Methylprednisolone—ulcerative colitis	0.00137	0.00169	CcSEcCtD
Roflumilast—Myalgia—Hydrocortisone—ulcerative colitis	0.00136	0.00167	CcSEcCtD
Roflumilast—Malaise—Triamcinolone—ulcerative colitis	0.00135	0.00167	CcSEcCtD
Roflumilast—Anxiety—Hydrocortisone—ulcerative colitis	0.00135	0.00167	CcSEcCtD
Roflumilast—Malaise—Methylprednisolone—ulcerative colitis	0.00135	0.00166	CcSEcCtD
Roflumilast—Vertigo—Triamcinolone—ulcerative colitis	0.00135	0.00166	CcSEcCtD
Roflumilast—Hypersensitivity—Mesalazine—ulcerative colitis	0.00135	0.00166	CcSEcCtD
Roflumilast—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—ulcerative colitis	0.00135	0.00166	CcSEcCtD
Roflumilast—Vertigo—Methylprednisolone—ulcerative colitis	0.00135	0.00166	CcSEcCtD
Roflumilast—Discomfort—Hydrocortisone—ulcerative colitis	0.00134	0.00165	CcSEcCtD
Roflumilast—Connective tissue disorder—Prednisone—ulcerative colitis	0.00134	0.00165	CcSEcCtD
Roflumilast—Nausea—Budesonide—ulcerative colitis	0.00134	0.00165	CcSEcCtD
Roflumilast—Dizziness—Azathioprine—ulcerative colitis	0.00133	0.00164	CcSEcCtD
Roflumilast—Asthenia—Mesalazine—ulcerative colitis	0.00131	0.00162	CcSEcCtD
Roflumilast—Infection—Hydrocortisone—ulcerative colitis	0.00129	0.00159	CcSEcCtD
Roflumilast—Myalgia—Triamcinolone—ulcerative colitis	0.00128	0.00157	CcSEcCtD
Roflumilast—Vomiting—Azathioprine—ulcerative colitis	0.00128	0.00157	CcSEcCtD
Roflumilast—Nervous system disorder—Hydrocortisone—ulcerative colitis	0.00128	0.00157	CcSEcCtD
Roflumilast—Myalgia—Methylprednisolone—ulcerative colitis	0.00127	0.00157	CcSEcCtD
Roflumilast—Anxiety—Methylprednisolone—ulcerative colitis	0.00127	0.00157	CcSEcCtD
Roflumilast—Rash—Azathioprine—ulcerative colitis	0.00127	0.00156	CcSEcCtD
Roflumilast—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	0.00127	0.00156	CcSEcCtD
Roflumilast—Dermatitis—Azathioprine—ulcerative colitis	0.00127	0.00156	CcSEcCtD
Roflumilast—Skin disorder—Hydrocortisone—ulcerative colitis	0.00126	0.00156	CcSEcCtD
Roflumilast—Ill-defined disorder—Dexamethasone—ulcerative colitis	0.00126	0.00156	CcSEcCtD
Roflumilast—Ill-defined disorder—Betamethasone—ulcerative colitis	0.00126	0.00156	CcSEcCtD
Roflumilast—PDE4D—TSH signaling pathway—STAT3—ulcerative colitis	0.00126	0.0067	CbGpPWpGaD
Roflumilast—Discomfort—Triamcinolone—ulcerative colitis	0.00126	0.00156	CcSEcCtD
Roflumilast—Discomfort—Methylprednisolone—ulcerative colitis	0.00126	0.00155	CcSEcCtD
Roflumilast—Headache—Azathioprine—ulcerative colitis	0.00126	0.00155	CcSEcCtD
Roflumilast—Diarrhoea—Mesalazine—ulcerative colitis	0.00125	0.00154	CcSEcCtD
Roflumilast—Angioedema—Betamethasone—ulcerative colitis	0.00124	0.00153	CcSEcCtD
Roflumilast—Angioedema—Dexamethasone—ulcerative colitis	0.00124	0.00153	CcSEcCtD
Roflumilast—Immune system disorder—Prednisone—ulcerative colitis	0.00123	0.00152	CcSEcCtD
Roflumilast—Malaise—Betamethasone—ulcerative colitis	0.00123	0.00151	CcSEcCtD
Roflumilast—Malaise—Dexamethasone—ulcerative colitis	0.00123	0.00151	CcSEcCtD
Roflumilast—PDE4B—Myometrial Relaxation and Contraction Pathways—ADCY5—ulcerative colitis	0.00123	0.00652	CbGpPWpGaD
Roflumilast—Vertigo—Dexamethasone—ulcerative colitis	0.00122	0.00151	CcSEcCtD
Roflumilast—Vertigo—Betamethasone—ulcerative colitis	0.00122	0.00151	CcSEcCtD
Roflumilast—Infection—Triamcinolone—ulcerative colitis	0.00122	0.0015	CcSEcCtD
Roflumilast—Infection—Methylprednisolone—ulcerative colitis	0.00121	0.0015	CcSEcCtD
Roflumilast—Dizziness—Mesalazine—ulcerative colitis	0.00121	0.00149	CcSEcCtD
Roflumilast—Insomnia—Prednisolone—ulcerative colitis	0.0012	0.00148	CcSEcCtD
Roflumilast—Nervous system disorder—Methylprednisolone—ulcerative colitis	0.0012	0.00148	CcSEcCtD
Roflumilast—Mental disorder—Prednisone—ulcerative colitis	0.00119	0.00147	CcSEcCtD
Roflumilast—Nausea—Azathioprine—ulcerative colitis	0.00119	0.00147	CcSEcCtD
Roflumilast—Skin disorder—Methylprednisolone—ulcerative colitis	0.00119	0.00146	CcSEcCtD
Roflumilast—Malnutrition—Prednisone—ulcerative colitis	0.00119	0.00146	CcSEcCtD
Roflumilast—Musculoskeletal discomfort—Hydrocortisone—ulcerative colitis	0.00119	0.00146	CcSEcCtD
Roflumilast—Insomnia—Hydrocortisone—ulcerative colitis	0.00118	0.00145	CcSEcCtD
Roflumilast—Vomiting—Mesalazine—ulcerative colitis	0.00116	0.00143	CcSEcCtD
Roflumilast—Myalgia—Betamethasone—ulcerative colitis	0.00116	0.00143	CcSEcCtD
Roflumilast—Myalgia—Dexamethasone—ulcerative colitis	0.00116	0.00143	CcSEcCtD
Roflumilast—Anxiety—Dexamethasone—ulcerative colitis	0.00116	0.00142	CcSEcCtD
Roflumilast—Anxiety—Betamethasone—ulcerative colitis	0.00116	0.00142	CcSEcCtD
Roflumilast—Rash—Mesalazine—ulcerative colitis	0.00115	0.00142	CcSEcCtD
Roflumilast—Dermatitis—Mesalazine—ulcerative colitis	0.00115	0.00142	CcSEcCtD
Roflumilast—Headache—Mesalazine—ulcerative colitis	0.00115	0.00141	CcSEcCtD
Roflumilast—Discomfort—Dexamethasone—ulcerative colitis	0.00115	0.00141	CcSEcCtD
Roflumilast—Discomfort—Betamethasone—ulcerative colitis	0.00115	0.00141	CcSEcCtD
Roflumilast—Dyspepsia—Hydrocortisone—ulcerative colitis	0.00115	0.00141	CcSEcCtD
Roflumilast—Decreased appetite—Hydrocortisone—ulcerative colitis	0.00113	0.00139	CcSEcCtD
Roflumilast—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	0.00112	0.00138	CcSEcCtD
Roflumilast—Fatigue—Hydrocortisone—ulcerative colitis	0.00112	0.00138	CcSEcCtD
Roflumilast—Musculoskeletal discomfort—Triamcinolone—ulcerative colitis	0.00112	0.00138	CcSEcCtD
Roflumilast—Musculoskeletal discomfort—Methylprednisolone—ulcerative colitis	0.00111	0.00137	CcSEcCtD
Roflumilast—Insomnia—Triamcinolone—ulcerative colitis	0.00111	0.00137	CcSEcCtD
Roflumilast—Insomnia—Methylprednisolone—ulcerative colitis	0.00111	0.00136	CcSEcCtD
Roflumilast—Infection—Betamethasone—ulcerative colitis	0.0011	0.00136	CcSEcCtD
Roflumilast—Infection—Dexamethasone—ulcerative colitis	0.0011	0.00136	CcSEcCtD
Roflumilast—Ill-defined disorder—Prednisone—ulcerative colitis	0.0011	0.00136	CcSEcCtD
Roflumilast—Feeling abnormal—Prednisolone—ulcerative colitis	0.0011	0.00135	CcSEcCtD
Roflumilast—Nervous system disorder—Dexamethasone—ulcerative colitis	0.00109	0.00134	CcSEcCtD
Roflumilast—Nervous system disorder—Betamethasone—ulcerative colitis	0.00109	0.00134	CcSEcCtD
Roflumilast—Nausea—Mesalazine—ulcerative colitis	0.00109	0.00134	CcSEcCtD
Roflumilast—Angioedema—Prednisone—ulcerative colitis	0.00108	0.00134	CcSEcCtD
Roflumilast—Dyspepsia—Triamcinolone—ulcerative colitis	0.00108	0.00133	CcSEcCtD
Roflumilast—Dyspepsia—Methylprednisolone—ulcerative colitis	0.00108	0.00133	CcSEcCtD
Roflumilast—Feeling abnormal—Hydrocortisone—ulcerative colitis	0.00107	0.00132	CcSEcCtD
Roflumilast—Malaise—Prednisone—ulcerative colitis	0.00107	0.00132	CcSEcCtD
Roflumilast—Vertigo—Prednisone—ulcerative colitis	0.00107	0.00131	CcSEcCtD
Roflumilast—Gastrointestinal pain—Hydrocortisone—ulcerative colitis	0.00106	0.00131	CcSEcCtD
Roflumilast—Urticaria—Prednisolone—ulcerative colitis	0.00106	0.0013	CcSEcCtD
Roflumilast—Fatigue—Triamcinolone—ulcerative colitis	0.00106	0.0013	CcSEcCtD
Roflumilast—Fatigue—Methylprednisolone—ulcerative colitis	0.00105	0.0013	CcSEcCtD
Roflumilast—Urticaria—Hydrocortisone—ulcerative colitis	0.00103	0.00127	CcSEcCtD
Roflumilast—Abdominal pain—Hydrocortisone—ulcerative colitis	0.00103	0.00127	CcSEcCtD
Roflumilast—Musculoskeletal discomfort—Dexamethasone—ulcerative colitis	0.00101	0.00125	CcSEcCtD
Roflumilast—Musculoskeletal discomfort—Betamethasone—ulcerative colitis	0.00101	0.00125	CcSEcCtD
Roflumilast—Myalgia—Prednisone—ulcerative colitis	0.00101	0.00124	CcSEcCtD
Roflumilast—Feeling abnormal—Triamcinolone—ulcerative colitis	0.00101	0.00124	CcSEcCtD
Roflumilast—Feeling abnormal—Methylprednisolone—ulcerative colitis	0.00101	0.00124	CcSEcCtD
Roflumilast—Anxiety—Prednisone—ulcerative colitis	0.00101	0.00124	CcSEcCtD
Roflumilast—Insomnia—Betamethasone—ulcerative colitis	0.00101	0.00124	CcSEcCtD
Roflumilast—Insomnia—Dexamethasone—ulcerative colitis	0.00101	0.00124	CcSEcCtD
Roflumilast—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	0.001	0.00124	CcSEcCtD
Roflumilast—Gastrointestinal pain—Methylprednisolone—ulcerative colitis	0.000999	0.00123	CcSEcCtD
Roflumilast—Discomfort—Prednisone—ulcerative colitis	0.000998	0.00123	CcSEcCtD
Roflumilast—Hypersensitivity—Prednisolone—ulcerative colitis	0.000981	0.00121	CcSEcCtD
Roflumilast—Dyspepsia—Dexamethasone—ulcerative colitis	0.000978	0.00121	CcSEcCtD
Roflumilast—Dyspepsia—Betamethasone—ulcerative colitis	0.000978	0.00121	CcSEcCtD
Roflumilast—Urticaria—Triamcinolone—ulcerative colitis	0.000973	0.0012	CcSEcCtD
Roflumilast—Urticaria—Methylprednisolone—ulcerative colitis	0.000971	0.0012	CcSEcCtD
Roflumilast—Abdominal pain—Methylprednisolone—ulcerative colitis	0.000966	0.00119	CcSEcCtD
Roflumilast—Decreased appetite—Dexamethasone—ulcerative colitis	0.000966	0.00119	CcSEcCtD
Roflumilast—Decreased appetite—Betamethasone—ulcerative colitis	0.000966	0.00119	CcSEcCtD
Roflumilast—Infection—Prednisone—ulcerative colitis	0.000962	0.00118	CcSEcCtD
Roflumilast—Gastrointestinal disorder—Betamethasone—ulcerative colitis	0.00096	0.00118	CcSEcCtD
Roflumilast—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	0.00096	0.00118	CcSEcCtD
Roflumilast—Hypersensitivity—Hydrocortisone—ulcerative colitis	0.000958	0.00118	CcSEcCtD
Roflumilast—Fatigue—Betamethasone—ulcerative colitis	0.000958	0.00118	CcSEcCtD
Roflumilast—Fatigue—Dexamethasone—ulcerative colitis	0.000958	0.00118	CcSEcCtD
Roflumilast—Nervous system disorder—Prednisone—ulcerative colitis	0.000949	0.00117	CcSEcCtD
Roflumilast—PDE4C—GPCR downstream signaling—CXCR1—ulcerative colitis	0.000943	0.005	CbGpPWpGaD
Roflumilast—Skin disorder—Prednisone—ulcerative colitis	0.00094	0.00116	CcSEcCtD
Roflumilast—Asthenia—Hydrocortisone—ulcerative colitis	0.000933	0.00115	CcSEcCtD
Roflumilast—Feeling abnormal—Betamethasone—ulcerative colitis	0.000916	0.00113	CcSEcCtD
Roflumilast—Feeling abnormal—Dexamethasone—ulcerative colitis	0.000916	0.00113	CcSEcCtD
Roflumilast—Gastrointestinal pain—Betamethasone—ulcerative colitis	0.000909	0.00112	CcSEcCtD
Roflumilast—Gastrointestinal pain—Dexamethasone—ulcerative colitis	0.000909	0.00112	CcSEcCtD
Roflumilast—Hypersensitivity—Triamcinolone—ulcerative colitis	0.000902	0.00111	CcSEcCtD
Roflumilast—Hypersensitivity—Methylprednisolone—ulcerative colitis	0.0009	0.00111	CcSEcCtD
Roflumilast—Diarrhoea—Hydrocortisone—ulcerative colitis	0.00089	0.0011	CcSEcCtD
Roflumilast—Urticaria—Betamethasone—ulcerative colitis	0.000883	0.00109	CcSEcCtD
Roflumilast—Urticaria—Dexamethasone—ulcerative colitis	0.000883	0.00109	CcSEcCtD
Roflumilast—Musculoskeletal discomfort—Prednisone—ulcerative colitis	0.000882	0.00109	CcSEcCtD
Roflumilast—Dizziness—Prednisolone—ulcerative colitis	0.000881	0.00109	CcSEcCtD
Roflumilast—Asthenia—Triamcinolone—ulcerative colitis	0.000879	0.00108	CcSEcCtD
Roflumilast—Abdominal pain—Betamethasone—ulcerative colitis	0.000879	0.00108	CcSEcCtD
Roflumilast—Abdominal pain—Dexamethasone—ulcerative colitis	0.000879	0.00108	CcSEcCtD
Roflumilast—Asthenia—Methylprednisolone—ulcerative colitis	0.000877	0.00108	CcSEcCtD
Roflumilast—Insomnia—Prednisone—ulcerative colitis	0.000875	0.00108	CcSEcCtD
Roflumilast—Dizziness—Hydrocortisone—ulcerative colitis	0.00086	0.00106	CcSEcCtD
Roflumilast—PDE4C—Signaling by GPCR—CXCR1—ulcerative colitis	0.000856	0.00454	CbGpPWpGaD
Roflumilast—Dyspepsia—Prednisone—ulcerative colitis	0.000852	0.00105	CcSEcCtD
Roflumilast—Decreased appetite—Prednisone—ulcerative colitis	0.000841	0.00104	CcSEcCtD
Roflumilast—Rash—Prednisolone—ulcerative colitis	0.00084	0.00103	CcSEcCtD
Roflumilast—Dermatitis—Prednisolone—ulcerative colitis	0.000839	0.00103	CcSEcCtD
Roflumilast—Diarrhoea—Methylprednisolone—ulcerative colitis	0.000836	0.00103	CcSEcCtD
Roflumilast—Fatigue—Prednisone—ulcerative colitis	0.000835	0.00103	CcSEcCtD
Roflumilast—Headache—Prednisolone—ulcerative colitis	0.000834	0.00103	CcSEcCtD
Roflumilast—Constipation—Prednisone—ulcerative colitis	0.000828	0.00102	CcSEcCtD
Roflumilast—PDE4C—GPCR downstream signaling—CCL20—ulcerative colitis	0.000828	0.00439	CbGpPWpGaD
Roflumilast—Vomiting—Hydrocortisone—ulcerative colitis	0.000827	0.00102	CcSEcCtD
Roflumilast—PDE4D—GPCR downstream signaling—CXCR1—ulcerative colitis	0.000821	0.00435	CbGpPWpGaD
Roflumilast—Rash—Hydrocortisone—ulcerative colitis	0.00082	0.00101	CcSEcCtD
Roflumilast—Dermatitis—Hydrocortisone—ulcerative colitis	0.000819	0.00101	CcSEcCtD
Roflumilast—Headache—Hydrocortisone—ulcerative colitis	0.000815	0.001	CcSEcCtD
Roflumilast—Dizziness—Triamcinolone—ulcerative colitis	0.00081	0.000998	CcSEcCtD
Roflumilast—Dizziness—Methylprednisolone—ulcerative colitis	0.000808	0.000996	CcSEcCtD
Roflumilast—Feeling abnormal—Prednisone—ulcerative colitis	0.000798	0.000983	CcSEcCtD
Roflumilast—Asthenia—Dexamethasone—ulcerative colitis	0.000797	0.000983	CcSEcCtD
Roflumilast—Asthenia—Betamethasone—ulcerative colitis	0.000797	0.000983	CcSEcCtD
Roflumilast—Gastrointestinal pain—Prednisone—ulcerative colitis	0.000792	0.000975	CcSEcCtD
Roflumilast—Nausea—Prednisolone—ulcerative colitis	0.000791	0.000975	CcSEcCtD
Roflumilast—PDE4A—GPCR downstream signaling—CXCR1—ulcerative colitis	0.000781	0.00414	CbGpPWpGaD
Roflumilast—Vomiting—Triamcinolone—ulcerative colitis	0.000779	0.00096	CcSEcCtD
Roflumilast—PDE4C—GPCR downstream signaling—GNA12—ulcerative colitis	0.000778	0.00413	CbGpPWpGaD
Roflumilast—Vomiting—Methylprednisolone—ulcerative colitis	0.000777	0.000958	CcSEcCtD
Roflumilast—Nausea—Hydrocortisone—ulcerative colitis	0.000773	0.000952	CcSEcCtD
Roflumilast—Rash—Triamcinolone—ulcerative colitis	0.000772	0.000952	CcSEcCtD
Roflumilast—Dermatitis—Triamcinolone—ulcerative colitis	0.000772	0.000951	CcSEcCtD
Roflumilast—Rash—Methylprednisolone—ulcerative colitis	0.000771	0.00095	CcSEcCtD
Roflumilast—Dermatitis—Methylprednisolone—ulcerative colitis	0.00077	0.000949	CcSEcCtD
Roflumilast—Urticaria—Prednisone—ulcerative colitis	0.000769	0.000948	CcSEcCtD
Roflumilast—Headache—Triamcinolone—ulcerative colitis	0.000767	0.000946	CcSEcCtD
Roflumilast—Headache—Methylprednisolone—ulcerative colitis	0.000766	0.000943	CcSEcCtD
Roflumilast—Abdominal pain—Prednisone—ulcerative colitis	0.000765	0.000943	CcSEcCtD
Roflumilast—PDE4D—Myometrial Relaxation and Contraction Pathways—IL1B—ulcerative colitis	0.000761	0.00404	CbGpPWpGaD
Roflumilast—Diarrhoea—Betamethasone—ulcerative colitis	0.00076	0.000937	CcSEcCtD
Roflumilast—Diarrhoea—Dexamethasone—ulcerative colitis	0.00076	0.000937	CcSEcCtD
Roflumilast—PDE4C—Signaling by GPCR—CCL20—ulcerative colitis	0.000752	0.00399	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—CXCR1—ulcerative colitis	0.000745	0.00395	CbGpPWpGaD
Roflumilast—PDE4C—GPCR downstream signaling—CXCR2—ulcerative colitis	0.000738	0.00391	CbGpPWpGaD
Roflumilast—Dizziness—Dexamethasone—ulcerative colitis	0.000735	0.000906	CcSEcCtD
Roflumilast—Dizziness—Betamethasone—ulcerative colitis	0.000735	0.000906	CcSEcCtD
Roflumilast—Nausea—Triamcinolone—ulcerative colitis	0.000728	0.000897	CcSEcCtD
Roflumilast—Nausea—Methylprednisolone—ulcerative colitis	0.000726	0.000895	CcSEcCtD
Roflumilast—PDE4B—GPCR downstream signaling—CXCR1—ulcerative colitis	0.000723	0.00384	CbGpPWpGaD
Roflumilast—PDE4D—GPCR downstream signaling—CCL20—ulcerative colitis	0.00072	0.00382	CbGpPWpGaD
Roflumilast—Hypersensitivity—Prednisone—ulcerative colitis	0.000713	0.000879	CcSEcCtD
Roflumilast—PDE4D—Myometrial Relaxation and Contraction Pathways—NFKB1—ulcerative colitis	0.00071	0.00377	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—CXCR1—ulcerative colitis	0.000709	0.00376	CbGpPWpGaD
Roflumilast—Vomiting—Dexamethasone—ulcerative colitis	0.000707	0.000871	CcSEcCtD
Roflumilast—Vomiting—Betamethasone—ulcerative colitis	0.000707	0.000871	CcSEcCtD
Roflumilast—PDE4C—Signaling by GPCR—GNA12—ulcerative colitis	0.000707	0.00375	CbGpPWpGaD
Roflumilast—Rash—Betamethasone—ulcerative colitis	0.000701	0.000864	CcSEcCtD
Roflumilast—Rash—Dexamethasone—ulcerative colitis	0.000701	0.000864	CcSEcCtD
Roflumilast—Dermatitis—Dexamethasone—ulcerative colitis	0.0007	0.000863	CcSEcCtD
Roflumilast—Dermatitis—Betamethasone—ulcerative colitis	0.0007	0.000863	CcSEcCtD
Roflumilast—Headache—Dexamethasone—ulcerative colitis	0.000696	0.000858	CcSEcCtD
Roflumilast—Headache—Betamethasone—ulcerative colitis	0.000696	0.000858	CcSEcCtD
Roflumilast—Asthenia—Prednisone—ulcerative colitis	0.000694	0.000856	CcSEcCtD
Roflumilast—PDE4C—GPCR downstream signaling—CCR6—ulcerative colitis	0.000694	0.00368	CbGpPWpGaD
Roflumilast—PDE4A—GPCR downstream signaling—CCL20—ulcerative colitis	0.000686	0.00364	CbGpPWpGaD
Roflumilast—PDE4D—GPCR downstream signaling—GNA12—ulcerative colitis	0.000677	0.00359	CbGpPWpGaD
Roflumilast—PDE4B—Myometrial Relaxation and Contraction Pathways—IL1B—ulcerative colitis	0.00067	0.00356	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—CXCR2—ulcerative colitis	0.00067	0.00355	CbGpPWpGaD
Roflumilast—Diarrhoea—Prednisone—ulcerative colitis	0.000662	0.000816	CcSEcCtD
Roflumilast—Nausea—Betamethasone—ulcerative colitis	0.00066	0.000813	CcSEcCtD
Roflumilast—Nausea—Dexamethasone—ulcerative colitis	0.00066	0.000813	CcSEcCtD
Roflumilast—PDE4B—Signaling by GPCR—CXCR1—ulcerative colitis	0.000656	0.00348	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—CCL20—ulcerative colitis	0.000654	0.00347	CbGpPWpGaD
Roflumilast—PDE4A—GPCR downstream signaling—GNA12—ulcerative colitis	0.000645	0.00342	CbGpPWpGaD
Roflumilast—PDE4D—GPCR downstream signaling—CXCR2—ulcerative colitis	0.000642	0.00341	CbGpPWpGaD
Roflumilast—Dizziness—Prednisone—ulcerative colitis	0.00064	0.000789	CcSEcCtD
Roflumilast—PDE4B—GPCR downstream signaling—CCL20—ulcerative colitis	0.000634	0.00337	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—CCR6—ulcerative colitis	0.00063	0.00334	CbGpPWpGaD
Roflumilast—PDE4B—Myometrial Relaxation and Contraction Pathways—NFKB1—ulcerative colitis	0.000625	0.00332	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—CCL20—ulcerative colitis	0.000623	0.0033	CbGpPWpGaD
Roflumilast—Vomiting—Prednisone—ulcerative colitis	0.000615	0.000758	CcSEcCtD
Roflumilast—PDE4D—Signaling by GPCR—GNA12—ulcerative colitis	0.000615	0.00326	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—SEL1L—ulcerative colitis	0.000614	0.00326	CbGpPWpGaD
Roflumilast—PDE4A—GPCR downstream signaling—CXCR2—ulcerative colitis	0.000611	0.00324	CbGpPWpGaD
Roflumilast—PDE4C—GPCR downstream signaling—PTGER4—ulcerative colitis	0.000611	0.00324	CbGpPWpGaD
Roflumilast—Rash—Prednisone—ulcerative colitis	0.00061	0.000752	CcSEcCtD
Roflumilast—Dermatitis—Prednisone—ulcerative colitis	0.00061	0.000751	CcSEcCtD
Roflumilast—Headache—Prednisone—ulcerative colitis	0.000606	0.000747	CcSEcCtD
Roflumilast—PDE4D—GPCR downstream signaling—CCR6—ulcerative colitis	0.000604	0.0032	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—GNA12—ulcerative colitis	0.000597	0.00317	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—GNA12—ulcerative colitis	0.000585	0.00311	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—CXCR2—ulcerative colitis	0.000583	0.00309	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—CCL20—ulcerative colitis	0.000576	0.00306	CbGpPWpGaD
Roflumilast—Nausea—Prednisone—ulcerative colitis	0.000575	0.000708	CcSEcCtD
Roflumilast—PDE4A—GPCR downstream signaling—CCR6—ulcerative colitis	0.000575	0.00305	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—CXCR2—ulcerative colitis	0.000566	0.003	CbGpPWpGaD
Roflumilast—PDE4C—GPCR downstream signaling—GHRL—ulcerative colitis	0.000559	0.00297	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—CXCR2—ulcerative colitis	0.000555	0.00295	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—PTGER4—ulcerative colitis	0.000554	0.00294	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—CCR6—ulcerative colitis	0.000548	0.00291	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—GNA12—ulcerative colitis	0.000542	0.00287	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—SEL1L—ulcerative colitis	0.000535	0.00284	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—CCR6—ulcerative colitis	0.000532	0.00282	CbGpPWpGaD
Roflumilast—PDE4D—GPCR downstream signaling—PTGER4—ulcerative colitis	0.000532	0.00282	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—CCR6—ulcerative colitis	0.000522	0.00277	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—CXCR2—ulcerative colitis	0.000514	0.00273	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—SEL1L—ulcerative colitis	0.000509	0.0027	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—GHRL—ulcerative colitis	0.000508	0.00269	CbGpPWpGaD
Roflumilast—PDE4A—GPCR downstream signaling—PTGER4—ulcerative colitis	0.000506	0.00268	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—CXCR1—ulcerative colitis	0.000506	0.00268	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—CALM3—ulcerative colitis	0.000492	0.00261	CbGpPWpGaD
Roflumilast—PDE4D—GPCR downstream signaling—GHRL—ulcerative colitis	0.000487	0.00258	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—CCR6—ulcerative colitis	0.000483	0.00256	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—PTGER4—ulcerative colitis	0.000483	0.00256	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—SEL1L—ulcerative colitis	0.000471	0.0025	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—PTGER4—ulcerative colitis	0.000468	0.00248	CbGpPWpGaD
Roflumilast—PDE4A—GPCR downstream signaling—GHRL—ulcerative colitis	0.000463	0.00246	CbGpPWpGaD
Roflumilast—PDE4C—GPCR downstream signaling—ADRB2—ulcerative colitis	0.000463	0.00246	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—PTGER4—ulcerative colitis	0.000459	0.00244	CbGpPWpGaD
Roflumilast—PDE4D—Myometrial Relaxation and Contraction Pathways—IL6—ulcerative colitis	0.000446	0.00236	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—CCL20—ulcerative colitis	0.000444	0.00236	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—GHRL—ulcerative colitis	0.000442	0.00235	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—CXCR1—ulcerative colitis	0.00044	0.00234	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—GHRL—ulcerative colitis	0.000429	0.00227	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—CALM3—ulcerative colitis	0.000428	0.00227	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—PTGER4—ulcerative colitis	0.000425	0.00226	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—GHRL—ulcerative colitis	0.000421	0.00223	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—ADRB2—ulcerative colitis	0.00042	0.00223	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—CXCR1—ulcerative colitis	0.000419	0.00222	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—GNA12—ulcerative colitis	0.000417	0.00221	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—CALM3—ulcerative colitis	0.000407	0.00216	CbGpPWpGaD
Roflumilast—PDE4D—GPCR downstream signaling—ADRB2—ulcerative colitis	0.000403	0.00214	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—CXCR2—ulcerative colitis	0.000396	0.0021	CbGpPWpGaD
Roflumilast—PDE4C—GPCR downstream signaling—ADCY5—ulcerative colitis	0.000393	0.00208	CbGpPWpGaD
Roflumilast—PDE4B—Myometrial Relaxation and Contraction Pathways—IL6—ulcerative colitis	0.000392	0.00208	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—GHRL—ulcerative colitis	0.000389	0.00207	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—CXCR1—ulcerative colitis	0.000388	0.00206	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—CCL20—ulcerative colitis	0.000386	0.00205	CbGpPWpGaD
Roflumilast—PDE4A—GPCR downstream signaling—ADRB2—ulcerative colitis	0.000383	0.00203	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—CALM3—ulcerative colitis	0.000377	0.002	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—CCR6—ulcerative colitis	0.000372	0.00197	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—CCL20—ulcerative colitis	0.000368	0.00195	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—ADRB2—ulcerative colitis	0.000366	0.00194	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—GNA12—ulcerative colitis	0.000363	0.00193	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—ADCY5—ulcerative colitis	0.000357	0.00189	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—ADRB2—ulcerative colitis	0.000355	0.00188	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—MAML2—ulcerative colitis	0.000353	0.00187	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—ADRB2—ulcerative colitis	0.000348	0.00185	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—GNA12—ulcerative colitis	0.000346	0.00184	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—CXCR2—ulcerative colitis	0.000344	0.00183	CbGpPWpGaD
Roflumilast—PDE4D—GPCR downstream signaling—ADCY5—ulcerative colitis	0.000342	0.00181	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—CCL20—ulcerative colitis	0.00034	0.00181	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—CXCR2—ulcerative colitis	0.000328	0.00174	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—PTGER4—ulcerative colitis	0.000328	0.00174	CbGpPWpGaD
Roflumilast—PDE4A—GPCR downstream signaling—ADCY5—ulcerative colitis	0.000325	0.00173	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—CCR6—ulcerative colitis	0.000324	0.00172	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—ADRB2—ulcerative colitis	0.000322	0.00171	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—GNA12—ulcerative colitis	0.00032	0.0017	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—ADCY5—ulcerative colitis	0.00031	0.00165	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—CCR6—ulcerative colitis	0.000308	0.00164	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—MAML2—ulcerative colitis	0.000307	0.00163	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—CXCR2—ulcerative colitis	0.000303	0.00161	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—ADCY5—ulcerative colitis	0.000301	0.0016	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—GHRL—ulcerative colitis	0.0003	0.00159	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—ADCY5—ulcerative colitis	0.000296	0.00157	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—MAML2—ulcerative colitis	0.000292	0.00155	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—CALM3—ulcerative colitis	0.00029	0.00154	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—RIPK2—ulcerative colitis	0.000286	0.00152	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—CCR6—ulcerative colitis	0.000285	0.00151	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—PTGER4—ulcerative colitis	0.000285	0.00151	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—ADCY5—ulcerative colitis	0.000273	0.00145	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—PTGER4—ulcerative colitis	0.000271	0.00144	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—MAML2—ulcerative colitis	0.00027	0.00143	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—GHRL—ulcerative colitis	0.000261	0.00139	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—CALM3—ulcerative colitis	0.000253	0.00134	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—PTGER4—ulcerative colitis	0.000251	0.00133	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—RIPK2—ulcerative colitis	0.000249	0.00132	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—GHRL—ulcerative colitis	0.000248	0.00132	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—ADRB2—ulcerative colitis	0.000248	0.00132	CbGpPWpGaD
Roflumilast—PDE4C—GPCR downstream signaling—JAK2—ulcerative colitis	0.000245	0.0013	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—CALM3—ulcerative colitis	0.000241	0.00128	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—RIPK2—ulcerative colitis	0.000237	0.00126	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—GHRL—ulcerative colitis	0.00023	0.00122	CbGpPWpGaD
Roflumilast—PDE4C—GPCR downstream signaling—CXCL8—ulcerative colitis	0.000223	0.00119	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—CALM3—ulcerative colitis	0.000223	0.00118	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—JAK2—ulcerative colitis	0.000222	0.00118	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—RIPK2—ulcerative colitis	0.000219	0.00116	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—ADRB2—ulcerative colitis	0.000216	0.00115	CbGpPWpGaD
Roflumilast—PDE4C—GPCR downstream signaling—IL2—ulcerative colitis	0.000214	0.00113	CbGpPWpGaD
Roflumilast—PDE4D—GPCR downstream signaling—JAK2—ulcerative colitis	0.000213	0.00113	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—ADCY5—ulcerative colitis	0.000211	0.00112	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—ADRB2—ulcerative colitis	0.000206	0.00109	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—CXCL8—ulcerative colitis	0.000203	0.00108	CbGpPWpGaD
Roflumilast—PDE4A—GPCR downstream signaling—JAK2—ulcerative colitis	0.000203	0.00108	CbGpPWpGaD
Roflumilast—PDE4D—GPCR downstream signaling—CXCL8—ulcerative colitis	0.000195	0.00103	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—IL2—ulcerative colitis	0.000194	0.00103	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—JAK2—ulcerative colitis	0.000194	0.00103	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—ADRB2—ulcerative colitis	0.00019	0.00101	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—JAK2—ulcerative colitis	0.000188	0.000996	CbGpPWpGaD
Roflumilast—PDE4D—GPCR downstream signaling—IL2—ulcerative colitis	0.000186	0.000987	CbGpPWpGaD
Roflumilast—PDE4A—GPCR downstream signaling—CXCL8—ulcerative colitis	0.000185	0.000983	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—JAK2—ulcerative colitis	0.000184	0.000978	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—ADCY5—ulcerative colitis	0.000183	0.000973	CbGpPWpGaD
Roflumilast—PDE4A—GPCR downstream signaling—IL2—ulcerative colitis	0.000177	0.000939	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—CXCL8—ulcerative colitis	0.000177	0.000937	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—ADCY5—ulcerative colitis	0.000175	0.000926	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—CXCL8—ulcerative colitis	0.000171	0.000909	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—JAK2—ulcerative colitis	0.00017	0.000905	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—IL2—ulcerative colitis	0.000169	0.000896	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—CXCL8—ulcerative colitis	0.000168	0.000892	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—IL2—ulcerative colitis	0.000164	0.000869	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—ADCY5—ulcerative colitis	0.000162	0.000857	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—IL2—ulcerative colitis	0.000161	0.000853	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—CXCL8—ulcerative colitis	0.000156	0.000826	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—IL2—ulcerative colitis	0.000149	0.000789	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—JAK2—ulcerative colitis	0.000131	0.000697	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—RELA—ulcerative colitis	0.000127	0.000675	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—CXCL8—ulcerative colitis	0.00012	0.000636	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—IL2—ulcerative colitis	0.000115	0.000608	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—JAK2—ulcerative colitis	0.000114	0.000607	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—IL6—ulcerative colitis	0.000114	0.000605	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—RELA—ulcerative colitis	0.000111	0.000588	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—JAK2—ulcerative colitis	0.000109	0.000578	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—MMP9—ulcerative colitis	0.000108	0.000575	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—NFKB1—ulcerative colitis	0.000107	0.000569	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—RELA—ulcerative colitis	0.000105	0.000559	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—CXCL8—ulcerative colitis	0.000104	0.000554	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—JAK2—ulcerative colitis	0.000101	0.000534	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—IL2—ulcerative colitis	9.97e-05	0.000529	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—CXCL8—ulcerative colitis	9.93e-05	0.000527	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—IL6—ulcerative colitis	9.92e-05	0.000527	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—RELA—ulcerative colitis	9.75e-05	0.000518	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—STAT3—ulcerative colitis	9.64e-05	0.000512	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—IL2—ulcerative colitis	9.49e-05	0.000504	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—IL6—ulcerative colitis	9.45e-05	0.000501	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—MMP9—ulcerative colitis	9.44e-05	0.000501	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—NFKB1—ulcerative colitis	9.34e-05	0.000496	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—CXCL8—ulcerative colitis	9.19e-05	0.000488	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—MMP9—ulcerative colitis	8.98e-05	0.000477	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—TGFB1—ulcerative colitis	8.94e-05	0.000474	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—NFKB1—ulcerative colitis	8.89e-05	0.000472	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—IL2—ulcerative colitis	8.78e-05	0.000466	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—IL6—ulcerative colitis	8.74e-05	0.000464	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—STAT3—ulcerative colitis	8.39e-05	0.000445	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—MMP9—ulcerative colitis	8.31e-05	0.000441	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—NFKB1—ulcerative colitis	8.23e-05	0.000436	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—STAT3—ulcerative colitis	7.99e-05	0.000424	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—TGFB1—ulcerative colitis	7.78e-05	0.000413	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—TGFB1—ulcerative colitis	7.41e-05	0.000393	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—STAT3—ulcerative colitis	7.39e-05	0.000392	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—TP53—ulcerative colitis	7.36e-05	0.00039	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—TGFB1—ulcerative colitis	6.85e-05	0.000364	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—IL6—ulcerative colitis	6.73e-05	0.000357	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—TP53—ulcerative colitis	6.4e-05	0.00034	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—TP53—ulcerative colitis	6.1e-05	0.000323	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—IL6—ulcerative colitis	5.86e-05	0.000311	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—TP53—ulcerative colitis	5.64e-05	0.000299	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—IL6—ulcerative colitis	5.58e-05	0.000296	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—IL6—ulcerative colitis	5.16e-05	0.000274	CbGpPWpGaD
